{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:35:16Z","timestamp":1794897316821,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Myeloproliferative neoplasm-associated myelofibrosis is a clonal stem cell process characterized by pronounced bone marrow fibrosis associated with extramedullary hematopoiesis and splenomegaly. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents the only curative treatment leading to bone marrow fibrosis regression. Here we provide an in-depth skeletal characterization of myelofibrosis patients before and after allo-HSCT utilizing clinical high-resolution imaging, laboratory analyses, and bone biopsy studies. Despite unimpaired bone microarchitecture at peripheral skeletal sites, we observe a marked increase in bone mineral density at the lumbar spine and proximal femur, which is histologically related to severe bone marrow fibrosis and osteosclerosis, fully normalizing after allo-HSCT. Importantly, the regression of fibrosis is accompanied by vanishing osteosclerosis along with restored osteoclastic resorption activity and whole-body calcium homeostasis. Together, our results provide evidence for an extensive reconstruction of skeletal homeostasis by allo-HSCT in MF, leading to rapid resolution of osteosclerosis.<\/jats:p>","DOI":"10.1038\/s41467-025-55915-w","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T10:04:37Z","timestamp":1737367477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Mathias","family":"Sch\u00e4fersk\u00fcpper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-8983","authenticated-orcid":false,"given":"Alexander","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-0983","authenticated-orcid":false,"given":"Timur A.","family":"Yorgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-6794","authenticated-orcid":false,"given":"Felix N.","family":"von Brackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian M.","family":"Delsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Baranowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Gagelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6297-1847","authenticated-orcid":false,"given":"Francis","family":"Ayuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8576-0177","authenticated-orcid":false,"given":"Thorsten","family":"Schinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Amling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5103-9966","authenticated-orcid":false,"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1058-1307","authenticated-orcid":false,"given":"Tim","family":"Rolvien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"55915_CR1","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood-2016-10-696005","volume":"129","author":"AJ Mead","year":"2017","unstructured":"Mead, A. J. & Mullally, A. Myeloproliferative neoplasm stem cells. Blood 129, 1607\u20131616 (2017).","journal-title":"Blood"},{"key":"55915_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405 (2016).","journal-title":"Blood"},{"key":"55915_CR3","doi-asserted-by":"publisher","first-page":"16616","DOI":"10.1073\/pnas.0908107106","volume":"106","author":"H Haeno","year":"2009","unstructured":"Haeno, H., Levine, R. L., Gilliland, D. G. & Michor, F. A progenitor cell origin of myeloid malignancies. Proc. Natl. Acad. Sci. USA 106, 16616\u201316621 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"55915_CR4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2010.69","volume":"24","author":"A Tefferi","year":"2010","unstructured":"Tefferi, A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24, 1128\u20131138 (2010).","journal-title":"Leukemia"},{"key":"55915_CR5","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","volume":"369","author":"J Nangalia","year":"2013","unstructured":"Nangalia, J. et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N. Engl. J. Med. 369, 2391\u20132405 (2013).","journal-title":"N. Engl. J. Med."},{"key":"55915_CR6","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","volume":"379","author":"J Grinfeld","year":"2018","unstructured":"Grinfeld, J. et al. Classification and personalized prognosis in myeloproliferative neoplasms. N. Engl. J. Med. 379, 1416\u20131430 (2018).","journal-title":"N. Engl. J. Med."},{"key":"55915_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3324\/haematol.2015.141283","volume":"101","author":"AA Zahr","year":"2016","unstructured":"Zahr, A. A. et al. Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies. Haematologica 101, 660\u2013671 (2016).","journal-title":"Haematologica"},{"key":"55915_CR8","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1182\/blood.2021011480","volume":"139","author":"A Karagianni","year":"2022","unstructured":"Karagianni, A. & Ravid, K. Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes. Blood 139, 3127\u20133137 (2022).","journal-title":"Blood"},{"key":"55915_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/ajh.25230","volume":"93","author":"A Tefferi","year":"2018","unstructured":"Tefferi, A. Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management. Am. J. Hematol. 93, 1551\u20131560 (2018).","journal-title":"Am. J. Hematol."},{"key":"55915_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s11899-018-0447-9","volume":"13","author":"P Bose","year":"2018","unstructured":"Bose, P. & Verstovsek, S. Management of myelofibrosis-related cytopenias. Curr. Hematol. Malig. Rep. 13, 164\u2013172 (2018).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"55915_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-017-0527-7","volume":"10","author":"S Verstovsek","year":"2017","unstructured":"Verstovsek, S. et al. Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses. J. Hematol. Oncol. 10, 156 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"55915_CR12","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/bloodadvances.2019001084","volume":"4","author":"K Gowin","year":"2020","unstructured":"Gowin, K. et al. Survival following allogeneic transplant in patients with myelofibrosis. Blood Adv. 4, 1965\u20131973 (2020).","journal-title":"Blood Adv."},{"key":"55915_CR13","first-page":"879","volume":"20","author":"J Thiele","year":"2005","unstructured":"Thiele, J. et al. Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation. Histol. Histopathol. 20, 879\u2013889 (2005).","journal-title":"Histol. Histopathol."},{"key":"55915_CR14","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.exphem.2007.08.022","volume":"35","author":"N Kr\u00f6ger","year":"2007","unstructured":"Kr\u00f6ger, N. et al. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis. Exp. Hematol. 35, 1719\u20131722 (2007).","journal-title":"Exp. Hematol."},{"key":"55915_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/bjh.12581","volume":"163","author":"S Farmer","year":"2013","unstructured":"Farmer, S., Horvath-Puho, E., Vestergaard, H., Hermann, A. P. & Frederiksen, H. Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study. Br. J. Haematol. 163, 603\u2013610 (2013).","journal-title":"Br. J. Haematol."},{"key":"55915_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12185-015-1803-3","volume":"102","author":"S Farmer","year":"2015","unstructured":"Farmer, S. et al. Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers. Int. J. Hematol. 102, 67\u201375 (2015).","journal-title":"Int. J. Hematol."},{"key":"55915_CR17","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1182\/blood-2018-10-878926","volume":"133","author":"I Veletic","year":"2019","unstructured":"Veletic, I. et al. Myelofibrosis osteoclasts are clonal and functionally impaired. Blood 133, 2320\u20132324 (2019).","journal-title":"Blood"},{"key":"55915_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bjh.15061","volume":"183","author":"A Tefferi","year":"2018","unstructured":"Tefferi, A. et al. Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis. Br. J. Haematol. 183, 835\u2013838 (2018).","journal-title":"Br. J. Haematol."},{"key":"55915_CR19","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele, J. et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90, 1128\u20131132 (2005).","journal-title":"Haematologica"},{"key":"55915_CR20","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","volume":"115","author":"F Passamonti","year":"2010","unstructured":"Passamonti, F. et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 115, 1703\u20131708 (2010).","journal-title":"Blood"},{"key":"55915_CR21","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1038\/leu.2017.169","volume":"31","author":"F Passamonti","year":"2017","unstructured":"Passamonti, F. et al. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. Leukemia 31, 2726\u20132731 (2017).","journal-title":"Leukemia"},{"key":"55915_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1359\/jbmr.090728","volume":"25","author":"M Priemel","year":"2010","unstructured":"Priemel, M. et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J. Bone Miner. Res. 25, 305\u2013312 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"55915_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00277-005-0042-8","volume":"85","author":"J Thiele","year":"2006","unstructured":"Thiele, J. & Kvasnicka, H. M. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Ann. Hematol. 85, 226\u2013232 (2006).","journal-title":"Ann. Hematol."},{"key":"55915_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0869-8","volume":"31","author":"D Lekovic","year":"2014","unstructured":"Lekovic, D. et al. Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis. Med. Oncol. 31, 869 (2014).","journal-title":"Med. Oncol."},{"key":"55915_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.bbmt.2014.02.019","volume":"20","author":"N Kr\u00f6ger","year":"2014","unstructured":"Kr\u00f6ger, N. et al. Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis. Biol. Blood Marrow Transplant. 20, 812\u2013815 (2014).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"55915_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1586\/17474086.2015.1053456","volume":"8","author":"S Farmer","year":"2015","unstructured":"Farmer, S. et al. Bone morbidity in chronic myeloproliferative neoplasms. Expert Rev. Hematol. 8, 447\u2013456 (2015).","journal-title":"Expert Rev. Hematol."},{"key":"55915_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/gerona\/glt092","volume":"68","author":"KE Ensrud","year":"2013","unstructured":"Ensrud, K. E. Epidemiology of fracture risk with advancing age. J. Gerontol. A Biol. Sci. Med. Sci. 68, 1236\u20131242 (2013).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"55915_CR28","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.2967\/jnumed.115.166348","volume":"57","author":"T Derlin","year":"2016","unstructured":"Derlin, T. et al. Serial 18F-FDG PET for Monitoring treatment response after allogeneic stem cell transplantation for myelofibrosis. J. Nucl. Med. 57, 1556\u20131559 (2016).","journal-title":"J. Nucl. Med."},{"key":"55915_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bone.2019.04.004","volume":"124","author":"Y Lim","year":"2019","unstructured":"Lim, Y. et al. Changes in trabecular bone score and bone mineral density following allogeneic hematopoietic stem cell transplantation. Bone 124, 40\u201346 (2019).","journal-title":"Bone"},{"key":"55915_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jbmr.3901","volume":"35","author":"N Mikolajewicz","year":"2020","unstructured":"Mikolajewicz, N. et al. HR-pQCT measures of bone microarchitecture predict fracture: systematic review and meta-analysis. J. Bone Miner. Res. 35, 446\u2013459 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"55915_CR31","doi-asserted-by":"crossref","unstructured":"Sarfati, M., et al. Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX: bone microarchitecture international consortium (BoMIC) prospective cohorts. J. Bone Miner. Res. 39, 1547\u20131583 (2024).","DOI":"10.1093\/jbmr\/zjae143"},{"key":"55915_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung, M. R. et al. Romosozumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 370, 412\u2013420 (2014).","journal-title":"N. Engl. J. Med."},{"key":"55915_CR33","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jocd.2019.09.001","volume":"22","author":"LG Jankowski","year":"2019","unstructured":"Jankowski, L. G. et al. Cross-calibration, least significant change and quality assurance in multiple dual-energy X-ray absorptiometry scanner environments: 2019 ISCD official position. J. Clin. Densitom. 22, 472\u2013483 (2019).","journal-title":"J. Clin. Densitom."},{"key":"55915_CR34","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00198-020-05438-5","volume":"31","author":"DE Whittier","year":"2020","unstructured":"Whittier, D. E. et al. Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography. Osteoporos. Int. 31, 1607\u20131627 (2020).","journal-title":"Osteoporos. Int."},{"key":"55915_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bone.2011.10.003","volume":"50","author":"JB Pialat","year":"2012","unstructured":"Pialat, J. B., Burghardt, A. J., Sode, M., Link, T. M. & Majumdar, S. Visual grading of motion induced image degradation in high resolution peripheral computed tomography: impact of image quality on measures of bone density and micro-architecture. Bone 50, 111\u2013118 (2012).","journal-title":"Bone"},{"key":"55915_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00223-013-9808-5","volume":"94","author":"S Hansen","year":"2014","unstructured":"Hansen, S., Shanbhogue, V., Folkestad, L., Nielsen, M. M. & Brixen, K. Bone microarchitecture and estimated strength in 499 adult Danish women and men: a cross-sectional, population-based high-resolution peripheral quantitative computed tomographic study on peak bone structure. Calcif. Tissue Int. 94, 269\u2013281 (2014).","journal-title":"Calcif. Tissue Int."},{"key":"55915_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2\u201317 (2013).","journal-title":"J. Bone Miner. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55915-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55915-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55915-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T10:04:39Z","timestamp":1737367479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55915-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55915"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-55915-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"30 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"741"}}